Follow
Rajal B. Shah
Rajal B. Shah
Dr. Charles T. Ashworth Professor of Pathology, University of Texas Southwestern Medical Center
Verified email at utsouthwestern.edu
Title
Cited by
Cited by
Year
Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer
SA Tomlins, DR Rhodes, S Perner, SM Dhanasekaran, R Mehra, XW Sun, ...
science 310 (5748), 644-648, 2005
47952005
Delineation of prognostic biomarkers in prostate cancer
SM Dhanasekaran, TR Barrette, D Ghosh, R Shah, S Varambally, ...
Nature 412 (6849), 822-826, 2001
21482001
Integrative molecular concept modeling of prostate cancer progression
SA Tomlins, R Mehra, DR Rhodes, X Cao, L Wang, SM Dhanasekaran, ...
Nature genetics 39 (1), 41-51, 2007
10912007
Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer
SA Tomlins, B Laxman, SM Dhanasekaran, BE Helgeson, X Cao, ...
Nature 448 (7153), 595-599, 2007
10022007
Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression
S Varambally, J Yu, B Laxman, DR Rhodes, R Mehra, SA Tomlins, ...
Cancer cell 8 (5), 393-406, 2005
8892005
Role of the TMPRSS2-ERG gene fusion in prostate cancer
SA Tomlins, B Laxman, S Varambally, X Cao, J Yu, BE Helgeson, Q Cao, ...
Neoplasia 10 (2), 177-IN9, 2008
8802008
Temporal activation of p53 by a specific MDM2 inhibitor is selectively toxic to tumors and leads to complete tumor growth inhibition
S Shangary, D Qin, D McEachern, M Liu, RS Miller, S Qiu, ...
Proceedings of the National Academy of Sciences 105 (10), 3933-3938, 2008
8132008
Androgen-independent prostate cancer is a heterogeneous group of diseases: lessons from a rapid autopsy program
RB Shah, R Mehra, AM Chinnaiyan, R Shen, D Ghosh, M Zhou, ...
Cancer research 64 (24), 9209-9216, 2004
7272004
TMPRSS2: ETV4 gene fusions define a third molecular subtype of prostate cancer
SA Tomlins, R Mehra, DR Rhodes, LR Smith, D Roulston, BE Helgeson, ...
Cancer research 66 (7), 3396-3400, 2006
5842006
Prostate-specific membrane antigen expression as a predictor of prostate cancer progression
S Perner, MD Hofer, R Kim, RB Shah, H Li, P Möller, RE Hautmann, ...
Human pathology 38 (5), 696-701, 2007
5562007
A polycomb repression signature in metastatic prostate cancer predicts cancer outcome
J Yu, J Yu, DR Rhodes, SA Tomlins, X Cao, G Chen, R Mehra, X Wang, ...
Cancer research 67 (22), 10657-10663, 2007
4072007
The role of SPINK1 in ETS rearrangement-negative prostate cancers
SA Tomlins, DR Rhodes, J Yu, S Varambally, R Mehra, S Perner, ...
Cancer cell 13 (6), 519-528, 2008
4012008
Comprehensive assessment of TMPRSS2 and ETS family gene aberrations in clinically localized prostate cancer
R Mehra, SA Tomlins, R Shen, O Nadeem, L Wang, JT Wei, KJ Pienta, ...
Modern Pathology 20 (5), 538-544, 2007
3782007
Characterization of TMPRSS2-ETS gene aberrations in androgen-independent metastatic prostate cancer
R Mehra, SA Tomlins, J Yu, X Cao, L Wang, A Menon, MA Rubin, ...
Cancer research 68 (10), 3584-3590, 2008
3322008
Noninvasive detection of TMPRSS2: ERG fusion transcripts in the urine of men with prostate cancer
B Laxman, SA Tomlins, R Mehra, DS Morris, L Wang, BE Helgeson, ...
Neoplasia 8 (10), 885-888, 2006
3212006
Clear cell papillary renal cell carcinoma: a distinct histopathologic and molecular genetic entity
S Gobbo, JN Eble, DJ Grignon, G Martignoni, GT MacLennan, RB Shah, ...
The American journal of surgical pathology 32 (8), 1239-1245, 2008
3142008
Comparison of the basal cell-specific markers, 34βE12 and p63, in the diagnosis of prostate cancer
RB Shah, M Zhou, M LeBlanc, M Snyder, MA Rubin
The American journal of surgical pathology 26 (9), 1161-1168, 2002
3082002
Prevalence of TMPRSS2-ERG fusion prostate cancer among men undergoing prostate biopsy in the United States
JM Mosquera, R Mehra, MM Regan, S Perner, EM Genega, G Bueti, ...
Clinical cancer research 15 (14), 4706-4711, 2009
2852009
Characterization of TMPRSS2-ERG fusion high-grade prostatic intraepithelial neoplasia and potential clinical implications
JM Mosquera, S Perner, EM Genega, M Sanda, MD Hofer, KD Mertz, ...
Clinical Cancer Research 14 (11), 3380-3385, 2008
2792008
Integrative genomics analysis reveals silencing of β-adrenergic signaling by polycomb in prostate cancer
J Yu, Q Cao, R Mehra, B Laxman, J Yu, SA Tomlins, CJ Creighton, ...
Cancer cell 12 (5), 419-431, 2007
2712007
The system can't perform the operation now. Try again later.
Articles 1–20